Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PTPN11 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | NPSR1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | CDC123 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | OR6C70 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | ISM1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | MEGF10 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | PIP5K1B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | TUBB | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | C1QA | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | CUL5 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |